American Life Science Pharmaceuticals (United States)
- Research works
- 39 ▲ 3% vs 2013–17
- Citations
- 3.4k 88.2 per fractional work
- Top-10% rate
- 34.6% record average 16.5%
- Open access
- 34% world 28%
Not ranked overall: American Life Science Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Dentistry, 12.6×. Every wedge is a field page.
Which keywords describe research at American Life Science Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Neurodegeneration, Oxidative Stress, Neuroinflammation, Amyloid Hypothesis, Tau Pathology, Cancer, Inflammation and Antiretroviral Therapy.
- Renewable Energy
- Health Care Spending
- Fluid Dynamics
- AIDS
- Immune Activation
- Clinical Practice Guidelines
- Calcium Modulated Proteins
- Cell Signaling
- Immune Response
- Angiogenesis
- Glycosylation
- Metastasis
- Chemotherapy-Induced Peripheral Neuropathy
- Quality of Life
- Amyloid Hypothesis
- Neuroinflammation
- Oxidative Stress
- Neurodegeneration
- Inflammation
- Cancer
- Tau Pathology
- Antiretroviral Therapy
- Taxanes
- Vaccine
- Innate Immunity
- Epidemiology
- Traumatic Brain Injury
- Sustainability
- Cancer Therapy
- Corporate Governance
- S100 Proteins
- HIV
- Gene Expression
- Insurance Markets
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 34 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 34 words, with their numbers
- Neurodegeneration4▲ 34×4 topics
- Oxidative Stress4▲ 5.3×8 topics
- Inflammation3▲ 3.4×9 topics
- Neuroinflammation3▲ 27×3 topics
- Cancer3▲ 5.2×8 topics
- Amyloid Hypothesis3▲ 124×1 topic
- Tau Pathology3▲ 124×1 topic
- Quality of Life2▲ 4.6×3 topics
- Antiretroviral Therapy2▲ 23×3 topics
- Chemotherapy-Induced Peripheral Neuropathy2▲ 100×1 topic
- Taxanes2▲ 100×1 topic
- Metastasis2▲ 14×5 topics
- Vaccine2▲ 11×3 topics
- Glycosylation2▲ 19×2 topics
- Innate Immunity2▲ 11×3 topics
- Angiogenesis1▲ 8.7×5 topics
- Epidemiology1◆ 0.88×7 topics
- Immune Response1▲ 6.0×3 topics
- Traumatic Brain Injury1▲ 35×2 topics
- Cell Signaling1▲ 10.0×4 topics
- Sustainability1▲ 1.93×2 topics
- Calcium Modulated Proteins1▲ 132×1 topic
- Cancer Therapy1▲ 4.8×5 topics
- Clinical Practice Guidelines1▲ 5.4×3 topics
- Corporate Governance1▲ 5.8×4 topics
- Immune Activation1▲ 34×2 topics
- S100 Proteins1▲ 132×1 topic
- AIDS1▲ 54×1 topic
- HIV1▲ 24×1 topic
- Fluid Dynamics1▲ 17×1 topic
- Gene Expression1▲ 4.2×3 topics
- Health Care Spending1▲ 40×1 topic
- Insurance Markets1▲ 40×1 topic
- Renewable Energy1▲ 2.6×1 topic
Which research topics does American Life Science Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Blood disorders and treatments, Neutropenia and Cancer Infections, Organizational Leadership and Management Strategies and Cancer Treatment and Pharmacology.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Blood disorders and treatments Genetics 0 works
- 2 Neutropenia and Cancer Infections Oncology 0 works
- 3 Organizational Leadership and Management Strategies Strategy and Management 0 works
- 4 Cancer Treatment and Pharmacology Oncology 0 works
- 5 Health disparities and outcomes Health 0 works
- 6 Food Security and Health in Diverse Populations General Health Professions 0 works
- 7 PARP inhibition in cancer therapy Oncology 0 works
- 8 Public Health Policies and Education General Health Professions 0 works
- 9 Antibiotics Pharmacokinetics and Efficacy Pharmacology 0 works
- 10 Corporate Finance and Governance Accounting 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has American Life Science Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 3% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in La Jolla
- Scripps Institution of Oceanography
- Salk Institute for Biological Studies
- Scripps Clinic
- Sanford Burnham Prebys Medical Discovery Institute
- National University
- Neurosciences Institute
- La Jolla Alcohol Research
- Behavioral Pharma (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.